- Home
- SFL vs TXG Comparison
SFL vs TXG Comparison
Compare SFL & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SFL
- TXG
- Stock Information
- Founded
- SFL 2003
- TXG 2012
- Country
- SFL Bermuda
- TXG United States
- Employees
- SFL N/A
- TXG N/A
- Industry
- SFL Marine Transportation
- TXG Biotechnology: Laboratory Analytical Instruments
- Sector
- SFL Consumer Discretionary
- TXG Industrials
- Exchange
- SFL Nasdaq
- TXG Nasdaq
- Market Cap
- SFL 1.1B
- TXG 1.0B
- IPO Year
- SFL N/A
- TXG 2019
- Fundamental
- Price
- SFL $8.59
- TXG $9.53
- Analyst Decision
- SFL Strong Buy
- TXG Buy
- Analyst Count
- SFL 1
- TXG 15
- Target Price
- SFL $13.00
- TXG $15.81
- AVG Volume (30 Days)
- SFL 1.0M
- TXG 3.7M
- Earning Date
- SFL 05-14-2025
- TXG 05-08-2025
- Dividend Yield
- SFL 12.59%
- TXG N/A
- EPS Growth
- SFL N/A
- TXG N/A
- EPS
- SFL 0.41
- TXG N/A
- Revenue
- SFL $852,590,000.00
- TXG $624,662,000.00
- Revenue This Year
- SFL N/A
- TXG N/A
- Revenue Next Year
- SFL $4.92
- TXG $6.74
- P/E Ratio
- SFL $21.15
- TXG N/A
- Revenue Growth
- SFL 6.58
- TXG N/A
- 52 Week Low
- SFL $6.78
- TXG $6.78
- 52 Week High
- SFL $14.42
- TXG $24.76
- Technical
- Relative Strength Index (RSI)
- SFL 55.68
- TXG 58.21
- Support Level
- SFL $8.41
- TXG $8.07
- Resistance Level
- SFL $8.64
- TXG $9.42
- Average True Range (ATR)
- SFL 0.24
- TXG 0.50
- MACD
- SFL -0.01
- TXG 0.06
- Stochastic Oscillator
- SFL 55.63
- TXG 84.93
About SFL SFL Corporation Ltd
SFL Corp Ltd is an international ship-owning and chartering company. The company is engaged in transporting crude oil and oil products, dry bulk and containerized cargoes, freight of rolling cargo, and offshore drilling and related activities.
About TXG 10x Genomics Inc.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).